Skip to main
SBTX
SBTX logo

Silverback Therapeutics (SBTX) Earnings Dates & Reports

Silverback Therapeutics (SBTX) Most Recent Earnings

Report Date
Period EndingQ4 2021
Est. EPS-$0.70
Actual EPS-$0.67
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Silverback Therapeutics (SBTX) Earnings per Share (EPS) History

Signup for full access
Browse free

Silverback Therapeutics (SBTX) Latest Earnings

The value each SBTX share was expected to gain vs. the value each share gained.

Silverback Therapeutics (SBTX) reported its most recent earnings on for Q4 2021, posting earnings per share (EPS) of -$0.67. This exceeded analysts' expectations of -$0.70 by 4.29%, marking a Beat.

For comparison, Silverback Therapeutics reported EPS of -$1.37 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.

Silverback Therapeutics (SBTX) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2022
-$0.55
DeckReportListen
Q1 2022
-$0.70
DeckReportListen
Q4 2021
-$0.70-$0.67-4.29%
DeckReportListen
Q3 2021
-$0.67-$0.65-2.99%
DeckReportListen
Q2 2021
-$0.53-$0.70+32.08%
DeckReportListen
View all

Silverback Therapeutics (SBTX) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Silverback Therapeutics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

Silverback Therapeutics (SBTX) Earnings FAQs

Silverback Therapeutics (SBTX) last reported earnings on Mar 31, 2022 for Q4 2021, posting an EPS of -$0.67, which Beat the estimate of -$0.70 by 4.29%.

For Q4 2021, Silverback Therapeutics (SBTX) reported an EPS of -$0.67, exceeding analysts' estimate of -$0.70 by 4.29%.

For Q4 2021, Silverback Therapeutics (SBTX) Beat expectations with an actual EPS of -$0.67 vs. an estimated EPS of -$0.70.

Following the last earnings report on Mar 31, 2022, Silverback Therapeutics (SBTX)'s stock price moved — from — to —.

The next Silverback Therapeutics (SBTX) earnings call is scheduled for Aug. 11, 2022, where executives will discuss financial results and outlook.

Silverback Therapeutics (SBTX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.